Dudediligence.

Rallybio Corporation

RLYBNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$299,000Sep ’24$38,000Dec ’24$212,000Mar ’25$212,000Jun ’25$212,000Sep ’25$222,000Dec ’25$212,000Mar ’26$0.00Jun ’26
Net income, by quarter
−$11.5MSep ’24−$11.0MDec ’24−$9.4MMar ’25−$9.7MJun ’25$16.0MSep ’25−$5.9MDec ’25−$8.3MMar ’26$43.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$636,000$858,000
Operating income−$45.6M−$67.9M−$78.9M−$60.5M−$33.1M
Net income−$47.0M−$66.7M−$74.6M−$57.8M−$9.0M
Operating cash flow−$45.5M−$57.3M−$60.3M−$49.3M−$29.8M
Free cash flow−$45.9M−$57.3M−$60.3M−$49.3Mnone on file
Cash$175.3M$57.0M$24.5M$13.9M$31.4M
Shares outstanding32.1M37.8M37.8M5.2M5.3M